CNETS is committed to improving the quality of life and survival for NET patients across Canada. To deliver on this vision, CNETS  has been supporting NET research since 2011, initially through a partnership-based approach and since 2016 through our independent Research Funding Framework.

This is the seventh year in which we are offering research grants across Canada for NET cancer research based on our framework.

CNETS is pleased to announce the 2022 Neuroendocrine Tumour Research Grant Competition, to provide grant-in-aid for 3 (THREE) NET cancer research projects, up to a maximum of $40,000 per project.

One of these grants-in-aid will be funded through the “Daniels Constellation Fund for Neuroendocrine Cancer Research thanks to the tremendous fundraising efforts of Bailey and Jonathan Daniels.


Relevance of the application to the focused area of Neuroendocrine Tumour (NET) cancer research.

The eligible project must involve a clinical trial or a clinical or fundamental research project (including animal or cellular models) to examine issues relevant for the understanding of the origin and development of Neuroendocrine tumors (NETs), their diagnosis and treatment.

The onus is on the applicant to justify the request in terms of its relevance to the diagnosis and therapy for NET patients by these selected approaches.

Preference will be given to projects that could have a direct and meaningful impact on the lives NET patients.

To harness the unique insight only a patient or caregiver can provide, CNETS encourages applications with patient and caregiver engagement in the project design and execution.


Call for Applications: November 15, 2022

Application Submission Deadline: December 20, 2022

Anticipated Notification of Decisions: January 15, 2023

Funding Availability / Start Date: 2 years starting April 1, 2023

Share This Story, Choose Your Platform!